-
公开(公告)号:EP1461446A2
公开(公告)日:2004-09-29
申请号:EP02799014.2
申请日:2002-09-19
发明人: WARREN, Bridget, A. , EMERLING, Brooke, M. , LEE, Ernestine, A. , CHANG, Hsin-Ru , FORSYTHE, Ian, J. , GRIFFIN, Jennifer, A. , BAUGHN, Mariah, R. , CHAWLA, Narinder, K. , KHARE, Reena , REDDY, Roopa , LEE, Sally , BULLOCH, Sean, A , LEE, Soo, Yeun , TRAN, Uyen, K. , ELLIOTT, Vicki, S. , TANG, Y. , Tom , BHATIA, Umesh , BURRILL, John, D. , BLAKE, Julie, J. , HO, Anne , ZHENG, Wenjin
CPC分类号: C12N9/20 , A61K38/00 , C07K14/47 , C07K14/4702
摘要: Various embodiments of the invention provide human lipid-associatedmolecules (LIPAM) and polynucleotides which identify and encode LIPAM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LIPAM.
-
公开(公告)号:EP1487989A2
公开(公告)日:2004-12-22
申请号:EP02794113.7
申请日:2002-11-25
发明人: TANG, Y., Tom , CHAWLA, Narinder, K. , LU, Dyung Aina, M. , KHAN, Farrah, A. , GANDHI, Ameena, R. , SWARNAKAR, Anita , AZIMZAI, Yalda , MARQUIS, Joseph, P. , SPRAGUE, William, W. , EMERLING, Brooke, M. , YUE, Henry , BOROWSKY, Mark, L. , BECHA, Shanya, D. , ISON, Craig, H. , ELLIOTT, Vicki, S. , HAFALIA, April, J., A. , RING, Huijun, Z. , WARREN, Bridget, A. , GIETZEN, Kimberly, J. , TRAN, Uyen K. , LEE, Soo Yeun , LEE, Ernestine A. , RICHARDSON, Thomas W. , KABLE, Amy E. , BURFORD, Neil , LEHR-MASON, Patricia M. , GORVARD, Ann E. , LEE, Sally , BLAKE, Julie J. , HONCHELL, Cynthia D. , THANGAVELU, Kavitha , RAMKUMAR, Jayalaxmi , CHIEN, David , JIN, Pei , CHANG, Hsin-Ru , BAUGHN, Mariah R. , NGUYEN, Danniel B. , KHARE, Reena , BHATIA, Umesh , BURRILL, John D. , HO, Anne , ZHENG, Wenjin
CPC分类号: C07K14/47
摘要: Various embodiments of the invention provide human molecules for diseasedetection and treatment (MDDT) and polynucleotides which identify and encode MDDT. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of MDDT.
-
公开(公告)号:EP1451212A2
公开(公告)日:2004-09-01
申请号:EP02780462.4
申请日:2002-10-10
发明人: BECHA, Shanya, D. , BHATIA, Umesh , BLAKE, Julie, J. , BOROWSKY, Mark, L. , BURRILL, John, D. , CHANG, Hsin-Ru , CHAWLA, Narinder, K. , ELLIOTT, Vicki, S. , EMERLING, Brooke, M. , FORSYTHE, Ian, J. , GORVAD, Ann, E. , GRIFFIN, Jennifer, A. , HAFALIA, April, J., A. , HO, Anne , ISON, Craig, H. , KABLE, Amy, E. , KHARE, Reena , LAL, Preeti, G. , LEE, Sally , LEE, Ernestine A. , LEE, Soo Yeun , LEHR-MASON, Patricia M. , LI, Joana X. , LINDQUIST, Erika A. , LUO, Wen , MARQUIS, Joseph P. , RAMKUMAR, Jayalaxmi , RICHARDSON, Thomas W. , SPRAGUE, William W. , SWARNAKAR, Anita , TANG, Y. Tom , WARREN, Bridget A. , YANG, Junming , YUE, Henry , ZEBARJADIAN, Yeganeh , ZHENG, Wenjin
摘要: Various embodiments of the invention provide human structural and cytoskeleton-associated proteins (SCAP) and polynucleotides which identify and encode SCAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SCAP.
-
公开(公告)号:EP1434785A2
公开(公告)日:2004-07-07
申请号:EP02780461.6
申请日:2002-10-11
发明人: RAMKUMAR, Jayalaxmi , GORVAD, Ann, E. , BAUGHN, Mariah, R. , EMERLING, Brooke, M. , YANG, Junming , LEE,soo,Yeun , TRAN, Uyen, K. , BECHA, Shanya, D. , DUGGAN, Brendan, M. , LEE, Ernestine, A. , GRIFFIN, Jennifer, A. , LI,Joana, X. , SPRAGUE, William, W. , HAFALIA, April, J.A. , CHAWLA, Narinder, K. , LEHR-MASON, Patricia, M. , KABLE, Amy, E. , YUE, Henry , MARQUIS, Joseph, P. , YAO, Monique G. , RICHARDSON, Thomas W. , TANG, Tom Y. , JIN, Pei , CHIEN, David , BHATIA, Umesh , BURRILL, John D. , LEE, Sally , BLAKE, Julie J. , HO, Anne , ZHENG, Wenjin
CPC分类号: A01K67/00 , A61K38/00 , A61K38/17 , A61K39/395 , A61K45/00 , C07H21/04 , C07K14/47 , C07K16/18 , C07K16/40 , C12M1/00 , C12N1/20 , C12N5/10 , C12N9/00 , C12N15/02 , C12N15/09 , C12N15/52 , C12P21/02 , C12Q1/68 , G01N1/00 , G01N33/15 , G01N33/50 , G01N33/53 , G01N33/566
摘要: Various embodiments of the invention provide human protein modification and maintenance molecules(PMMM) and polynucleotides which identify and encode PMMM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMMM.
-
公开(公告)号:EP1504101A2
公开(公告)日:2005-02-09
申请号:EP02786702.7
申请日:2002-11-07
发明人: KABLE, Amy, E. , SWARNAKAR, Anita , GORVAD, Ann, E. , HAFALIA, April, J.A. , DUGGAN, Brendan, M. , WARREN, Bridget, A. , EMERLING, Brooke, M. , ISON, Craig, H. , NGUYEN, Danniel, B. , LINDQUIST, Erika, A. , LEE, Ernestine, A. , YUE, Henry , YUE, Huibin , FORSYTHE, Ian, J. , RAMKUMAR, Jayalaxmi , GRIFFIN, Jennifer, A. , LI, Joana, X. , MARQUIS, Joseph, P. , GIETZEN, Kimberly, J. , BAUGHN, Mariah R. , BOROWSKY, Mark L. , YAO, Monique G. , CHAWLA, Narinder K. , LEHR-MASON, Patricia M. , LAL, Preeti G. , GURURAJAN, Rajagopal , KHARE, Reena , BATRA, Sajeev , BECNA, Shanya, D. , LEE, Soo Yeun , TRAN, Uyen K. , ELLIOTT, Vicki S. , SPRAGUE, William W. , TANG, Y. Tom , ZEBARJADIAN, Yeganeh , JIANG, Xin , JACKSON, Alan A. , BHATIA, Umesh , BURRILL, John D. , LEE, Sally , BLAKE, Julie J. , HO, Anne , ZHENG, Wenjin
CPC分类号: C07K14/47
摘要: Various ernbodiments of the invention provide human intracellular signaling molecules (INTSIG) and polynucleotides which identify and encode INTSIG. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of INTSIG.
-
公开(公告)号:EP1480994A1
公开(公告)日:2004-12-01
申请号:EP02792392.9
申请日:2002-12-12
发明人: BAUGHN, Mariah, R. , BHATIA, Umesh , BLAKE, Julie, J. , BURRILL, John, D. , ELLIOTT, Vicki, S. , EMERLING, Brooke, M. , FORSYTHE, Ian, J. , GIETZEN, Kimberly, J. , GORVAD, Ann, E. , GRIFFIN, Jennifer, A. , HAFALIA, April, J.A. , HO, Anne , JACKSON, Alan, A. , JIANG, Xin , KABLE, Amy, E. , KEARNEY, Liam , KHARE, Reena , LEE, Ernestine, A. , LEE, Sally , LU, Dyung Aina M. , MARQUIS, Joseph P. , LEHR-MASON, Patricia M. , RAMKUMAR, Jayalaxmi , RICHARDSON, Thomas W. , SPRAGUE, William W. , TRAN, Uyen K. , CHAWLA, Narinder K. , WARREN, Bridget A. , YUE, Henry , ZHENG, Wenjin
CPC分类号: C07K14/47
摘要: Various embodiments of the invention provide human neurotransmission-associated proteins (NTRAN) and polynucleotides which identify and encode NTRAN. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NTRAN.
-
公开(公告)号:EP1434860A2
公开(公告)日:2004-07-07
申请号:EP02783990.1
申请日:2002-09-26
发明人: YANG, Junming , LU, Dyung Aina, M. , YUE, Henry , ELLIOTT, Vicki, S. , WARREN, Bridget, A. , DUGGAN, Brendan, M. , FORSYTHE, Ian, J. , LEE, Ernestine, A. , HAFALIA, April, J.A. , RAMKUMAR, Jayalaxmi , CHAWLA, Narinder, K. , BAUGHN, Mariah, R. , BECHA, Shanya, D. , GORVAD, Anne, E. , TRAN, Uyen, K. , LI, Joana, X. , YAO, Monique, G. , ISON, Craig, H. , GRIFFIN, Jennifer, A. , CHANG, Hsin-Ru , EMERLING, Brooke, M. , TANG, Y. Tom , LAL, Preeti G. , KABLE, Amy E. , MARQUIS, Joseph P. , JIANG, Xin , JACKSON, Alan A. , ZEBARJADIAN, Yeganeh , SWARNAKAR, Anita , WILSON, Amy D. , JIN, Pei , RICHARDSON, Thomas W. , BHATIA, Umesh , BURRILL, John C. , LEE, Sally , BLAKE, Julie J. , HO, Anne , ZHENG, Wenjin , GAO, Jing , LEE, Soo Yeun
CPC分类号: C07K14/4702 , A61K38/00 , C12N9/20
摘要: Various embodiments of the invention provide human enzymes (ENZM) and polynucleotides which identify and encode ENZM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ENZM.
-
-
-
-
-
-